ASCRS 2024: Key features of LASIK using an updated laser ablation algorithm for myopia and myopic astigmatism
At ASCRS2024, George O. Waring IV, MD, FACS, provides an overview of his presentation highlighting outcomes for LASIK performed using an updated laser ablation algorithm
Cataract surgery pre-treatment with miLoop: Shorter lensectomy time, less irrigation needed
Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting
ESCRS president Filomena Ribeiro invites ASCRS attendees to 'cataract Olympiad' after successful Refractive Day
Filomena Ribeiro, MD, PhD, FEBO, discusses her presentation on neuroadaptation following the ASCRS Refractive Day
ASCRS 2024: CoFi integrates with CareCredit and marks participation milestone for ophthalmologists and optometrists
Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration
ASCRS 2024: New Phase III study results and near-future plans for Neurotech and NT-501
Rich Small, CEO of Neurotech Pharmaceuticals, provides an update on the months ahead for NT-501 encapsulated cell therapy
Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center
Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation
Evaluation of an enhanced monofocal intraocular lens
Three IOLs are evaluated in a randomised study
Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition
Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages
ARxVision, Seeing AI, NaviLens announce partnership for headset programme
The UK's Royal National Institute of Blind People is the global distributor of the headset and ARxVision is partnering with the National Federation of the Blind and Vision Australia to expand global accessibility
Women in ophthalmology series: Ms Neeru A Vallabh gives advice for finding multiple mentors
The glaucoma specialist talks about navigating the world of research, and the realities of motherhood, as a clinician
Increase in the incidence rate of conjunctival melanoma in Australia
Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period
Global partnership targets ROP in premature infants
An AI-supported telemedicine effort from Siloam Vision and Orbis International
Exonate shares results from Phase Ib/IIa trial of EXN407 eye drops for DR and DME
In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407
Genetic editing untangles one strand of the AMD web
The opportunities and challenges presented by CRISPR manipulation
Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration
The European Commission is expected to make a decision about the application before the end of June
An alternative approach to spectacle independence
Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs
How amyloid-beta peptide and tau protein demonstrate degeneration
Proteins common to Alzheimer disease play a significant role in glaucoma
Focusing on functional vision with monofocal lenses
Quantitative and qualitative improvement in IOL design
Assessing long-term impact of ocular injuries after motor vehicle accidents
Researchers investigated patients' ability to drive and work following eye injury
COPHy 2024: Should all elderly patients with acute visual loss go to the emergency department?
A case study emphasises the shifting paradigm in clinical best practices
COPHy 2024: Intraocular inflammation as a risk factor resulting from use of anti-complement agents for GA
Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease
COPHy 2024: Is artificial intelligence ready to replace physicians?
Retina specialists Giuseppe Querques, MD, PhD, and Paolo Lanzetta, MD, debate at the Congress on Controversies in Ophthalmology
COPHy 2024: How good are we really without artificial intelligence tools?
At this year's Congress on Controversies in Ophthalmology, keynote speaker Ursula Schmidt-Erfurth, MD, addressed the clinical use of artificial intelligence
Smokers more likely to experience vision loss
Research indicates smoking increases risk of AMD, cataracts and glaucoma
Kiora publishes results from Phase 1 study demonstrating safety, tolerability and efficacy of KIO-101
Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year
Children with amblyopia have increased risk of serious diseases as adults
Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases
Women in ophthalmology series: Dr Alexandra Miere encourages young ophthalmologists to step out of the comfort zone
The retina specialist shares advice for the clinician-scientists of a digital-centric future
Women in ophthalmology series: Dr Filomena Ribeiro on the importance of equity in education
Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them
Surgical taming of neurotrophic keratopathy: From amniotic membrane grafting to neurotisation
Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation
United States FDA approves clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals and AimMax Therapeutics
The approval marks the first new steroid on the US ophthalmic market in more than 15 years
